- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05004779
Regenerative Effects of Human Stem Cell Media After Laser Therapy in Hypertrophic Scar
August 9, 2021 updated by: Hangang Sacred Heart Hospital
Regenerative Effects of Human Stem Cell Media After Laser Therapy in Hypertrophic Scar Caused by Burns
The purpose of this study was to determine the effect of combined treatment using nonablative laser and human stem cell media (HSCM) on the regeneration of hypertrophic scars that occurred after burns.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
The purpose of this study was to determine the effect of combined treatment using nonablative laser and human stem cell media (HSCM) on the regeneration of hypertrophic scars that occurred after burns.
Nonablative laser treatment was performed on 30 patients with hypertrophic scars on both sides of the same part of the body.
Immediately after the laser treatment, the hypertrophic scars of right side to which HSCM was applied and the left side with the same body position were defined as a control scar, and normal saline was applied.
Over the next 6 days, HSCM and moisturizer were applied on the scars of right side, and only moisturizer was applied on the control scar of left side.
Laser treatment was performed three times on the hypertrophic scar at 4 weeks intervals.
The skin test on hypertrophic scar was evaluated before laser treatment and re-evaluated on the 7the day after the 3rd laser treatment.
The thickness was measured with a ultrasonic wave equipment (128 BW1 Medison, Korea).
Mexameter® (MX18, Courage-Khazaka Electronics GmbH, Germany) was used to measure melanin levels and the severity of erythema.
The higher values indicating a darker and redder skin.
Transepidermal water loss (TEWL) was measured with a Tewameter® (Courage-Khazaka Electronic GmbH, Germany), which is used for evaluating water evaporation.
Sebum in the scars was measured with the Sebumeter® (Courage-Khazaka Electronic GmbH, Germany).
The measurement is based on the principle of grease-spot photometry using a cassette with its special tape.
A microprocessor calculates the result, which is shown on the display in μg/cm2.
Elasticity was measured using Cutometer SEM 580® (Courage-Khazaka Electronic GmbH, Cologne, Germany), which applies negative pressure (450 mbar) on the skin.
The numeric values (mm) of the skin's distortion is presented as the elasticity (Table 1).
Two seconds of negative pressure of 450 mbar is followed by 2 s of recess, and this consists of a complete cycle.
Three measurement cycles were conducted, and the average values were obtained.
To evaluate the effect of HSCM, investigators compared the skin test results (thickness, melanin, erythema, TEWL, sebum, and skin elasticity levels) between the right side and control side, from baseline measures immediately before the laser treatment and measures on the 7the day after the 3rd laser treatment.
Outcome measurements and data analyses were performed by a trained and blinded outcome assessor who was not involved in the intervention.
Possible complications (pain, ecchymosis, skin abrasion, and swelling) were observed.
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- partial or full-thickness burns that healed spontaneously or required skin grafting
- with hypertrophic scars on the right and left sides of the same body part
Exclusion Criteria:
- Patients with open wounds or infection on the burn scars
- those taking steroids for the scars
- with allergies to topical anesthetic cream
- those who were pregnant
- undergoing any other medical treatment or condition affecting wound healing (e.g., diabetes)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: human stem cell media apply lesion
human media apply after non ablative laser treatment
|
After laser treatment on hypertrophic scars, human stem cell media was applied to one side
|
|
Sham Comparator: control condition lesion
normal saline apply after non ablative laser treatment
|
physiological saline was applied to the other side.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
scar thickness (cm)
Time Frame: baseline
|
The thickness was measured with a ultrasonic wave equipment
|
baseline
|
|
change from baseline scar thickness at 3 months (cm)
Time Frame: after 3 months intervention
|
the change of scar thickness was measured with a ultrasonic wave equipment
|
after 3 months intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
melanin levels (arbitraty units; AU)
Time Frame: baseline
|
the higher values indicating a darker
|
baseline
|
|
change from baseline melanin level at 3 months (arbitraty units; AU)
Time Frame: after 3 months intervention
|
the higher values indicating a darker
|
after 3 months intervention
|
|
erythema level (arbitraty units; AU)
Time Frame: baseline
|
the higher values indicating a redder skin
|
baseline
|
|
change from baseline erythema level at 3 months (arbitraty units; AU)
Time Frame: after 3 months intervention
|
the higher values indicating a redder skin
|
after 3 months intervention
|
|
transepidermal water loss (g/h/m2)
Time Frame: baseline
|
the higher the number, the more dry the skin is.
|
baseline
|
|
change from baseline transepidermal water loss at 3 months (g/h/m2)
Time Frame: after 3 months intervention
|
the higher the number, the more dry the skin is.
|
after 3 months intervention
|
|
Sebum level (μg sebum/cm2)
Time Frame: baseline
|
A microprocessor calculates the result, which is shown on the display in μg/cm2.
The higher the number, the more oily the skin is.
|
baseline
|
|
change from baseline sebum level at 3 months (μg sebum/cm2)
Time Frame: after 3 months intervention
|
A microprocessor calculates the result, which is shown on the display in μg/cm2.
The higher the number, the more oily the skin is.
|
after 3 months intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Onur Erol O, Agaoglu G, Jawad MA. Combined Non-Ablative Laser and Microfat Grafting for Burn Scar Treatment. Aesthet Surg J. 2019 Mar 14;39(4):NP55-NP67. doi: 10.1093/asj/sjy291.
- Jayaraman P, Nathan P, Vasanthan P, Musa S, Govindasamy V. Stem cells conditioned medium: a new approach to skin wound healing management. Cell Biol Int. 2013 Oct;37(10):1122-8. doi: 10.1002/cbin.10138. Epub 2013 Jun 24.
- Park IS. Enhancement of Wound Healing by Conditioned Medium of Adipose-Derived Stromal Cell with Photobiomodulation in Skin Wound. Int J Stem Cells. 2021 May 30;14(2):212-220. doi: 10.15283/ijsc20175.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 10, 2021
Primary Completion (Anticipated)
December 31, 2021
Study Completion (Anticipated)
April 20, 2022
Study Registration Dates
First Submitted
July 29, 2021
First Submitted That Met QC Criteria
August 9, 2021
First Posted (Actual)
August 13, 2021
Study Record Updates
Last Update Posted (Actual)
August 13, 2021
Last Update Submitted That Met QC Criteria
August 9, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HangangSHH-13
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stem Cell Media
-
Natural Immune Systems IncUnknownStem Cell Mobilization | Hematopoietic Stem Cell Mobilization | Stem Cell HomingUnited States
-
University of PittsburghNational Cancer Institute (NCI)RecruitingStem Cell Transplant | Hematopoetic Stem Cell Transplantation | Hematopoetic Stem Cell TransplantUnited States
-
Washington University School of MedicineNational Marrow Donor Program; Predictive BioDiagnostics, LLCCompletedHematopoietic Stem Cell Transplantation | Stem Cell Transplantation, Hematopoietic | Transplantation, Hematopoietic Stem CellUnited States
-
University Hospital, GenevaRecruitingAllogeneic Hematopoietic Stem Cell Transplantation | Hematopoietic Stem Cell Transplantation | Autologous Hematopoietic Stem Cell TransplantationSwitzerland
-
Hongnan MoUnknownHematopoietic Stem Cell Transplantation | Thrombocytopoietin | Hematopoietic Stem Cell MobilizationChina
-
Universitaire Ziekenhuizen KU LeuvenEnrolling by invitationHematopoietic Stem Cell Transplantation | Hematopoietic Stem Cell Transplantation, Allogeneic
-
Cairo UniversityActive, not recruitingStem Cell TransplantationEgypt
-
University of Kansas Medical CenterNational Institute of Nursing Research (NINR); Duke University; Stanford University and other collaboratorsRecruitingFood Insecurity | ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION | Autologous Haemopoietic Stem Cell Transplant | CAR-T Cell TherapyUnited States
-
BRIM Biotechnology Inc.University of PennsylvaniaAvailableLimbal Stem Cell Deficiency (LSCD)United States
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingStem Cell DonorsItaly
Clinical Trials on human stem cell conditioned media was applied after non-ablative laser therapy
-
Julio RamirezUniversity of LouisvilleTerminatedOsteomyelitisUnited States